[Story ID: 621]
Informatics Corporation of America (ICA), unmatched in its ability to deliver a cost-effective, proven solution that leverages complete data across clinical settings to aid decision-making and improve patient outcomes, announced that its CareAlign’
[Story ID: 439]
Quidel Corporation, a leading provider of rapid diagnostic tests, has completed its previously announced acquisition of Diagnostic Hybrids, Inc. for approximately $130 million in cash.
[Story ID: 419]
The EPO Enlarged Board of Appeal handed down its decision relating to the interpretation of the exclusion for patentability under article 53(c) EPC “method for treatment of the human or animal body by surgery”. Questions were asked to the Enlarged Board in a case about a medical imaging method, whereby a contrast agent [...]
[Story ID: 385]
GeneNews Limited , a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle. U.S.
[Story ID: 349]
Pacific Biomarkers, Inc., a leading provider of specialized biomarker and contract research services, today announced its operating results for the second quarter and first half of FY2010.
[Story ID: 296]
As part of its ongoing effort to promote healthy lifestyles and nutrition for kids and families, Disney today announced that it will develop a program in collaboration with First Lady Michelle Obama supporting ‘
[Story ID: 273]
Cancer Research UK’s commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
[Story ID: 172]
Merz Pharma Group today announced that it has been granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, by the U.S. Federal Trade Commission and the U.S. Department of Justice in connection with the previously announced US$5.45 per share cash tender offer made by [...]